1951 - 2000 of 8587 Results
Title
Year
- Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model2013OPENTitle: Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 5Start Page: e65129End Page: e65129Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0065129Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0065129&type=printableCitation Count: 72
- Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain2013OPENTitle: Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the BrainJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61694End Page: e61694Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061694Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061694&type=printableCitation Count: 37
- Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model2013OPENTitle: Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61700End Page: e61700Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061700Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061700&type=printableCitation Count: 117
- Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease2016OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5410378Citation Count: 25
-
OPENTitle: Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasmJournal Name: Protein Engineering, Design and SelectionPublisher: Oxford University Press (OUP)Vol: 23Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/protein/gzq022Best OA location URL: https://academic.oup.com/peds/article-pdf/23/6/489/17494272/gzq022.pdfCitation Count: 58
-
OPENTitle: mzStudio: A Dynamic Digital Canvas for User-Driven Interrogation of Mass Spectrometry DataJournal Name: ProteomesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/proteomes5030020Best OA location URL: https://www.mdpi.com/2227-7382/5/3/20/pdf?version=1501590909Citation Count: 25
- Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease2008OPENTitle: Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseaseJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 2Issue #: 10-11Start Page: 1484End Page: 1497Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/prca.200800043Best OA location URL: https://europepmc.org/articles/pmc3142616?pdf=renderCitation Count: 27
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?2010OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
- Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing2013OPENTitle: Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencingJournal Name: RNAPublisher: Cold Spring Harbor LaboratoryVol: 19Issue #: 5Start Page: 712End Page: 722Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1261/rna.036863.112Best OA location URL: http://rnajournal.cshlp.org/content/19/5/712.full.pdfCitation Count: 187
-
OPENTitle: CNTRICS Imaging Biomarkers Final Task Selection: Long-Term Memory and Reinforcement LearningJournal Name: Schizophrenia BulletinPublisher: Oxford University Press (OUP)Vol: 38Issue #: 1Start Page: 62End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/schbul/sbr168Best OA location URL: https://academic.oup.com/schizophreniabulletin/article-pdf/38/1/62/5351297/sbr168.pdfCitation Count: 28
-
OPENTitle: Caffeine and risk of Parkinson's disease in a large cohort of men and womenJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 10Start Page: 1276End Page: 1282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25076Citation Count: 183
-
OPENTitle: Mood and cognition in leucine‐rich repeat kinase 2 G2019S Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 10Start Page: 1875End Page: 1880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23746Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3972755Citation Count: 40
- Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients2013OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859714Citation Count: 7
-
OPENTitle: Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 1966End Page: 1971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25647Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859844Citation Count: 136
- Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implications2013OPENTitle: Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implicationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 9Start Page: 1301End Page: 1304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25496Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3760996Citation Count: 38
-
OPENTitle: Caffeine consumption and risk of dyskinesia in CALM‐PDJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 380End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3608707Citation Count: 54
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia2012OPENTitle: β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementiaJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 296End Page: 301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25213Best OA location URL: https://hdl.handle.net/2027.42/97160Citation Count: 87
-
OPENTitle: Disease‐related and genetic correlates of psychotic symptoms in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2190End Page: 2195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23806Best OA location URL: http://doi.org/10.1002/mds.23806Citation Count: 69
-
OPENTitle: Metabolomics and the search for biomarkers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1620End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25644Best OA location URL: http://doi.org/10.1002/mds.25644Citation Count: 10
-
OPENTitle: Reliability of a new scale for essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 12Start Page: 1567End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25162Citation Count: 205
-
OPENTitle: Maladaptive striatal plasticity in l-DOPA-induced dyskinesiaJournal Name: Progress in Brain ResearchPublisher: ElsevierVol:Issue #:Start Page: 209End Page: 233Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0079-6123(10)83011-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2930606Citation Count: 198
-
OPENTitle: MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms4633Best OA location URL: https://www.nature.com/articles/ncomms4633.pdfCitation Count: 282
- Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells2012OPENTitle: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cellsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms1669Best OA location URL: https://www.nature.com/articles/ncomms1669.pdfCitation Count: 241
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978804Citation Count: 23
-
OPENTitle: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms1085Best OA location URL: https://www.nature.com/articles/ncomms1085.pdfCitation Count: 151
-
OPENTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3140626Citation Count: 8
-
OPENTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
-
OPENTitle: The relationship between uric acid levels and Huntington's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 2Start Page: 224End Page: 228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22907Citation Count: 92
-
OPENTitle: Heart rate changes during freezing of gait in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 14Start Page: 2346End Page: 2354Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23280Best OA location URL: https://europepmc.org/articles/pmc2964413?pdf=renderCitation Count: 58
-
OPENTitle: Parkinson's disease, cortical dysfunction, and alpha‐synucleinJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1436End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23697Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3154995Citation Count: 23
- Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study2011OPENTitle: Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker StudyJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2283End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23934Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3337217Citation Count: 23
- Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations2011OPENTitle: Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1781End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23655Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3142314Citation Count: 19
-
OPENTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Citation Count: 42
-
OPENTitle: Comparison of enrollees and decliners of Parkinson disease sham surgery trialsJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 4Start Page: 506End Page: 511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24940Best OA location URL: https://hdl.handle.net/2027.42/90524Citation Count: 15
-
OPENTitle: Brain biochemistry in autopsied patients with essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 113End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3261329Citation Count: 55
-
OPENTitle: Brain amyloid and cognition in Lewy body diseasesJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 8Start Page: 965End Page: 973Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25048Citation Count: 168
- Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease2011OPENTitle: Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 11Start Page: 2051End Page: 2057Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23792Citation Count: 83
-
OPENTitle: Essential tremor and Parkinson's disease: Lack of a linkJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 3Start Page: 372End Page: 377Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23509Best OA location URL: https://europepmc.org/articles/pmc3070808?pdf=renderCitation Count: 62
-
OPENTitle: The association between Mediterranean diet adherence and Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 6Start Page: 771End Page: 774Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24918Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3349773Citation Count: 203
-
OPENTitle: Obesity, diabetes, and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2253End Page: 2259Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23855Citation Count: 155
-
OPENTitle: Genetic modification of the association of paraquat and Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 13Start Page: 1652End Page: 1658Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25216Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3572192Citation Count: 89
-
OPENTitle: Sham surgery controls in Parkinson's disease clinical trials: Views of participantsJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 11Start Page: 1461End Page: 1465Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25155Best OA location URL: https://hdl.handle.net/2027.42/93771Citation Count: 19
-
OPENTitle: Sustained attention training reduces spatial bias in Parkinson’s disease: a pilot case seriesJournal Name: NeurocasePublisher: Informa UK LimitedVol: 22Issue #: 2Start Page: 179End Page: 186Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/13554794.2015.1088035Best OA location URL: http://doi.org/10.1080/13554794.2015.1088035Citation Count: 13
- Oxidation-induced Structural Changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin Binding and Signaling2013OPENTitle: Oxidation-induced Structural Changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin Binding and SignalingJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 289Issue #: 6Start Page: 3736End Page: 3748Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m113.520981Best OA location URL: http://www.jbc.org/article/S0021925819747607/pdfCitation Count: 35
-
OPENTitle: Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharideJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 50Issue #: 4Start Page: 671End Page: 680Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2006.12.013Best OA location URL: http://doi.org/10.1016/j.neuint.2006.12.013Citation Count: 79
- Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations2012OPENTitle: Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterationsJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 145End Page: 156Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2012.12.001Best OA location URL: http://hdl.handle.net/11336/18335Citation Count: 49
- PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies2015OPENTitle: PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy BodiesJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 16Issue #: 1-2Start Page: 118End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000441421Best OA location URL: https://karger.com/ndd/article-pdf/16/1-2/118/3135738/000441421.pdfCitation Count: 49
-
OPENTitle: Investigating Convergent Actions of Genes Linked to Familial Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 5Issue #: 3-4Start Page: 182End Page: 185Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000113697Best OA location URL: https://www.karger.com/Article/Pdf/113697Citation Count: 43
-
OPENTitle: In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriersJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1197End Page: 1201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25893Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4139463Citation Count: 18
- Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography study2014OPENTitle: Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography studyJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25929Best OA location URL: https://hdl.handle.net/2027.42/108363Citation Count: 112